ANXA5 and ovarian carcinoma: Interestingly, in our study we found that the anti-CCP effect of GLT8D2 in ovarian cancer cells was significantly inhibited by treatment with FGFR inhibitor (TAS-120) or AKT inhibitor (GDC-0068) by colony formation and Annexin V-FITC assay.